Details of Drug-Drug Interaction
| Drug General Information (ID: DDIDFSUQ4E) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Olmesartan | Drug Info | Angiotensin II | Drug Info | |||||
| Drug Type | Small molecule | Hormones | |||||||
| Therapeutic Class | Antihypertensive Agents | Hormone Modulators | |||||||
| Structure | |||||||||
| Mechanism of Olmesartan-Angiotensin II Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antagonize the effect of antihypertensive agents Click to Show/Hide Mechanism Graph | |||||||||
 |
|||||||||
| Drug Name | Olmesartan | Angiotensin II | |||||||
| Mechanism |
Antihypertensive agent Angiotensin II receptor Antagonist |
Hypertensive effects Angiotensin II receptor Agonist |
|||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Angiotensin II receptor | Structure Sequence | |||||||
| Protein Family | G-protein coupled receptor 1 family | ||||||||
| Protein Function |
Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.; (Microbial infection) During SARS coronavirus-2/SARS-CoV-2 infection, it is able to recognize and internalize the complex formed by secreted ACE2 and SARS-CoV-2 spike protein through DNM2/dynamin 2-dependent endocytosis.
Click to Show/Hide
|
||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Close monitoring of therapeutic response is recommended when angiotensin II is administered to patients treated with angiotensin II receptor antagonists. | ||||||||